Your browser doesn't support javascript.
loading
Design, synthesis and biological evaluation of 2-pyrrolone derivatives as radioprotectors.
Satoh, Hidetoshi; Ochi, Shintaro; Mizuno, Kosuke; Saga, Yutaka; Ujita, Shohei; Toyoda, Miyu; Nishiyama, Yuichi; Tada, Kasumi; Matsushita, Yosuke; Deguchi, Yuichi; Suzuki, Keiji; Tanaka, Yoshimasa; Ueda, Hiroshi; Inaba, Toshiya; Hosoi, Yoshio; Morita, Akinori; Aoki, Shin.
Affiliation
  • Satoh H; Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, Japan.
  • Ochi S; Tokushima University, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan.
  • Mizuno K; Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, Japan.
  • Saga Y; Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, Japan.
  • Ujita S; Tokushima University, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan.
  • Toyoda M; Tokushima University, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan.
  • Nishiyama Y; Tokushima University, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan.
  • Tada K; Tokushima University, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan.
  • Matsushita Y; Tokushima University, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan; Department of Pharmacology and Therapeutic Innovation, Nagasaki University Graduate School of Biomedical Sciences, 1-14 Bunkyo-machi, Nagasaki 852-8521, Japan.
  • Deguchi Y; Center for Therapeutic Innovation, Nagasaki University Graduate School of Biomedical Sciences, 1-14 Bunkyo-machi, Nagasaki 852-8521, Japan.
  • Suzuki K; Department of Radiation Medical Sciences, Nagasaki University Atomic Bomb Disease Institute. 1-12-4 Sakamoto, Nagasaki 852-8523, Japan.
  • Tanaka Y; Center for Medical Innovation, Nagasaki University, 1-7-1 Sakamoto, Nagasaki 852-8588, Japan.
  • Ueda H; Department of Pharmacology and Therapeutic Innovation, Nagasaki University Graduate School of Biomedical Sciences, 1-14 Bunkyo-machi, Nagasaki 852-8521, Japan.
  • Inaba T; Research Institute for Radiation Biology and Medicine, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8553, Japan.
  • Hosoi Y; Department of Radiation Biology, Graduate School of Medicine, Tohoku University, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8575, Japan.
  • Morita A; Tokushima University, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan.
  • Aoki S; Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, Japan; Research Institute for Science and Technology, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, Japan; Research Institute for Biomedical Science, Tokyo University of Science,
Bioorg Med Chem ; 67: 116764, 2022 08 01.
Article in En | MEDLINE | ID: mdl-35635928
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tumor Suppressor Protein p53 / Apoptosis Type of study: Prognostic_studies Language: En Journal: Bioorg Med Chem Journal subject: BIOQUIMICA / QUIMICA Year: 2022 Document type: Article Affiliation country: Japón
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tumor Suppressor Protein p53 / Apoptosis Type of study: Prognostic_studies Language: En Journal: Bioorg Med Chem Journal subject: BIOQUIMICA / QUIMICA Year: 2022 Document type: Article Affiliation country: Japón